Drug Type Therapeutic vaccine, Genetically engineered subunit vaccine |
Synonyms ACAM FLU A |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza, Human | Phase 1 | United States | 01 Jul 2007 | |
Influenza A virus infection | Phase 1 | - | - | |
Influenza A virus infection | Phase 1 | - | - | |
Influenza A virus infection | Phase 1 | - | - |
Phase 1 | 87 | Alhydrogel+ACAM-FLU-A (ACAM-FLU-A Adjuvanted With Alhydrogel) | (gyuvporczf) = jrddcswogm zegzvubpns (jtewbqrgio, dbhinhltjn - knwlugonlx) View more | - | 16 Jan 2012 | ||
QS-21+ACAM-FLU-A (ACAM-FLU-A Adjuvanted With Stimulon® QS-21) | (gyuvporczf) = zlxzdnbvdf zegzvubpns (jtewbqrgio, mcwwgjhubx - adgpbqcmqd) View more |